Gender-related differences in the human subthalamic area: A local field potential study

European Journal of Neuroscience

Volumn 24, Issue 11, 2006, Pages 3213-3222

  Marceglia, S ^a   Mrakic Sposta, S ^a   Foffani, G ^a,b,c   Cogiamanian, F ^a   Caputo, E ^d   Egidi, M ^a   Barbieri, S ^a   Priori, A ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b DREXEL UNIVERSITY   (United States)

^c HOSPITAL NACIONAL DE PARAPLÉJICOS   (Spain)

^d FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

Basal ganglia; Electrophysiology; Gender; Parkinson's disease; Pathophysiology

Indexed keywords

ANTIDEPRESSANT AGENT; BENSERAZIDE PLUS LEVODOPA; CATECHOL METHYLTRANSFERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; HYPNOTIC AGENT; LEVODOPA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; SEDATIVE AGENT;

ADULT; AGED; ARTICLE; BASAL GANGLION; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; HUMAN; MALE; NEUROPHYSIOLOGY; OSCILLATION; PARKINSON DISEASE; PRIORITY JOURNAL; SEX DIFFERENCE; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

ACTION POTENTIALS; ADULT; AGED; ANTIPARKINSON AGENTS; BIOLOGICAL CLOCKS; CORPUS STRIATUM; DRUG RESISTANCE; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; NEURAL PATHWAYS; NEURONS; PARKINSON DISEASE; SEX CHARACTERISTICS; SUBTHALAMIC NUCLEUS;

EID: 33845661131     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2006.05208.x     Document Type: Article

References (87)

1. Allison, T., Wood, C.C. & Goff, W.R. (1983) Brain stem auditory, pattern-reversal visual, and short-latency somatosensory evoked potentials: latencies in relation to age, sex, and brain and body size. Electroencephalogr. Clin. Neurophysiol., 55, 619-636.
2. Alonso-Frech, F., Zamarbide, I., Alegre, M., Rodriguez-Oroz, M.C., Guridi, J., Manrique, M., Valencia, M., Artieda, J. & Obeso, J.A. (2006) Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease. Brain, 129, 1748-1757.
3. Arai, Y., Sekine, Y. & Murakami, S. (1996) Estrogen and apoptosis in the developing sexually dimorphic preoptic area in female rats. Neurosci. Res., 25, 403-407.
4. Baas, H.K. & Schueler, P. (2001) Efficacy of cabergoline in long-term use: results of three observational studies in 1,500 patients with Parkinson's disease. Eur. Neurol., 46 (Suppl. 1), 18-23.
5. Baker, S.N., Olivier, E. & Lemon, R.N. (1997) Coherent oscillations in monkey motor cortex and hand muscle EMG show task-dependent modulation. J. Physiol., 501, 225-241.
6. Becker, J.B. (1990) Direct effect of 17 beta-estradiol on striatum: sex differences in dopamine release. Synapse, 5, 157-164.
7. Becker, J.B. (1999) Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol. Biochem. Behav., 64, 803-812.
8. Becker, J.B. & Beer, M.E. (1986) The influence of estrogen on nigrostriatal dopamine activity: behavioral and neurochemical evidence for both pre- and postsynaptic components. Behav. Brain Res., 19, 27-33.
9. Becker, J.B. & Rudick, C.N. (1999) Rapid effects of estrogen or progesterone on the amphetamine-induced increase in striatal dopamine are enhanced by estrogen priming: a microdialysis study. Pharmacol. Biochem. Behav., 64, 53-57.
10. Benazzouz, A., Gross, C., Feger, J., Boraud, T. & Bioulac, B. (1993) Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur. J. Neurosci., 5, 382-389.
11. Bergman, H., Wichmann, T. & DeLong, M.R. (1990) Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science, 249, 1436-1438.
12. Beyer, C. & Karolczak, M. (2000) Estrogenic stimulation of neurite growth in midbrain dopaminergic neurons depends on cAMP/protein kinase A signalling. J. Neurosci. Res., 59, 107-116.
13. Bialek, M., Zaremba, P., Borowicz, K.K. & Czuczwar, S.J. (2004) Neuroprotective role of testosterone in the nervous system. Pol. J. Pharmacol., 56, 509-518.
14. Brenner, R.P., Ulrich, R.F., Reynolds, C.F., 3rd (1995) EEG spectral findings in healthy, elderly men and women - sex differences. Electroencephalogr. Clin. Neurophysiol., 94, 1-5.
15. Briere, M.E., Forest, G., Chouinard, S. & Godbout, R. (2003) Evening and morning EEG differences between young men and women adults. Brain Cogn., 53, 145-148.
16. Brown, P. (2003) Oscillatory nature of human basal ganglia activity: relationship to the pathophysiology of Parkinson's disease. Mov. Disord., 18, 357-363.
17. Brown, P., Oliviero, A., Mazzone, P., Insola, A., Tonali, P. & Di Lazzaro, V. (2001) Dopamine dependency of oscillations between subthalamic nucleus and pallidum in Parkinson's disease. J. Neurosci., 21, 1033-1038.
18. Brown, P. & Williams, D. (2005) Basal ganglia local field potential activity: character and functional significance in the human. Clin. Neurophysiol., 116, 2510-2519.
19. Cahill, L. (2006) Why sex matters for neuroscience. Nature Rev. Neurosci., 7, 477-484.
20. Carey, J.R., Deskin, K.A., Josephson, K.T. & Wichmann, R.L. (2002) Sex differences in tracking performance in patients with Parkinson's disease. Arch. Phys. Med. Rehabil., 83, 972-977.
21. Cassidy, M., Mazzone, P., Oliviero, A., Insola, A., Tonali, P., Di Lazzaro, V. & Brown, P. (2002) Movement-related changes in synchronization in the human basal ganglia. Brain, 125, 1235-1246.
22. Craig, M.C., Cutter, W.J., Wickham, H., van Amelsvoort, T.A., Rymer, J., Whitehead, M. & Murphy, D.G. (2004) Effect of long-term estrogen therapy on dopaminergic responsivity in post-menopausal women - a preliminary study. Psychoneuroendocrinology, 29, 1309-1316.
23. Creutzfeldt, O.D., Watanabe, S. & Lux, H.D. (1966) Relations between EEG phenomena and potentials of single cortical cells. I. Evoked responses after thalamic and erpicortical stimulation. Electroencephalogr. Clin. Neurophysiol., 20, 1-18.
24. Czlonkowska, A., Ciesielska, A., Gromadzka, G. & Kurkowska- Jastrzebska, I. (2005) Estrogen and cytokines production - the possible cause of gender differences in neurological diseases. Curr. Pharm. Des., 11, 1017-1030.
25. Dluzen, D.E. (1996) Effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system of C57/B1 mice. Brain Res., 715, 113-118.
26. Dluzen, D.E. (2000) Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system. J. Neurocytol., 29, 387-399.
27. Dluzen, D. & Horstink, M. (2003) Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies. Endocrine, 21, 67-75.
28. Dluzen, D.E. & McDermott, J.L. (2000a) Gender differences in neurotoxicity of the nigrostriatal dopaminergic system: implications for Parkinson's disease. J. Gend. Specif. Med., 3, 36-42.
29. Dluzen, D.E. & McDermott, J.L. (2000b) Neuroprotective role of estrogen upon methamphetamine and related neurotoxins within the nigrostriatal dopaminergic system. Ann. N.Y. Acad. Sci., 914, 112-126.
30. Dluzen, D.E., McDermott, J.L. & Liu, B. (1996a) Estrogen alters MPTP-induced neurotoxicity in female mice: effects on striatal dopamine concentrations and release. J. Neurochem., 66, 658-666.
31. Dluzen, D.E., McDermott, J.L. & Liu, B. (1996b) Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/B1 mice. Neurotoxicol. Teratol., 18, 603-606.
32. Donoghue, J.P., Sanes, J.N., Hatsopoulos, N.G. & Gaal, G. (1998) Neural discharge and local field potential oscillations in primate motor cortex during voluntary movements. J. Neurophysiol., 79, 159-173.
33. Doyle, L.M., Kuhn, A.A., Hariz, M., Kupsch, A., Schneider, G.H. & Brown, P. (2005) Levodopa-induced modulation of subthalamic beta oscillations during self-paced movements in patients with Parkinson's disease. Eur. J. Neurosci., 21, 1403-1412.
34. Egidi, M., Rampini, P., Locatelli, M., Farabola, M., Priori, A., Pesenti, A., Tamma, F., Caputo, E., Chiesa, V. & Villani, R.M. (2002) Visualisation of the subthalamic nucleus: a multiple sequential image fusion (MuSIF) technique for direct stereotaxic localisation and postoperative control. Neurol. Sci., 23 (Suppl. 2), S71-S72.
35. Erwin, C., Erwin, A.C., Hartewell, J.W. & Wilson, W.H. (1991) P100 latency as a function of head size. Am. JEEG Technol., 31, 279-288.
36. Federman, D.D. (2006) The biology of human sex differences. N. Engl. J. Med., 354, 1507-1514.
37. Foffani, G., Ardolino, G., Egidi, M., Caputo, E., Bossi, B. & Priori, A. (2006) Subthalamic oscillatory activities at beta or higher frequency do not change after high-frequency DBS in Parkinson's disease. Brain Res. Bull., 69, 123-130.
38. Foffani, G., Ardolino, G., Meda, B., Egidi, M., Rampini, P., Caputo, E., Baselli, G. & Priori, A. (2005a) Altered subthalamo-pallidal synchronisation in parkinsonian dyskinesias. J. Neurol. Neurosurg. Psychiatry, 76, 426-428.
39. Foffani, G., Ardolino, G., Rampini, P., Tamma, F., Caputo, E., Egidi, M., Cerutti, S., Barbieri, S. & Priori, A. (2005b) Physiological recordings from electrodes implanted in the basal ganglia for deep brain stimulation in Parkinson's disease. The Relevance Fast Subthalamic Rhythms. Acta Neurochir Suppl., 93, 97-99.
40. Foffani, G., Bianchi, A.M., Baselli, G. & Priori, A. (2005c) Movement-related frequency modulation of beta oscillatory activity in the human subthalamic nucleus. J. Physiol., 568, 699-711.
41. Foffani, G., Bianchi, A.M., Priori, A. & Baselli, G. (2004) Adaptive autoregressive identification with spectral power decomposition for studying movement-related activity in scalp EEG signals and basal ganglia local field potentials. J. Neural Eng., 1, 165-173.
42. Foffani, G., Priori, A., Egidi, M., Rampini, P., Tamma, F., Caputo, E., Moxon, K.A., Cerutti, S. & Barbieri, S. (2003) 300-Hz subthalamic oscillations in Parkinson's disease. Brain, 126, 2153-2163.
43. Fogelson, N., Williams, D., Tijssen, M., van Bruggen, G., Speelman, H. & Brown, P. (2006) Different functional loops between cerebral cortex and the subthalmic area in Parkinson's disease. Cereb. Cortex, 16, 64-75.
44. Frost, J.D. Jr (1968) EEG-intracellular potential relationships in isolated cerebral cortex. Electroencephalogr. Clin. Neurophysiol., 24, 434-443.
45. Goldberg, J.A., Rokni, U., Boraud, T., Vaadia, E. & Bergman, H. (2004) Spike synchronization in the cortex/basal-ganglia networks of Parkinsonian primates reflects global dynamics of the local field potentials. J. Neurosci., 24, 6003-6010.
46. Guivarc'h, D., Vernier, P. & Vincent, J.D. (1995) Sex steroid hormones change the differential distribution of the isoforms of the D2 dopamine receptor messenger RNA in the rat brain. Neuroscience, 69, 159-166.
47. Hariz, G.M., Lindberg, M., Hariz, M.I. & Bergenheim, A.T. (2003) Gender differences in disability and health-related quality of life in patients with Parkinson's disease treated with stereotactic surgery. Acta Neurol. Scand., 108, 28-37.
48. Hertrich, I. & Ackermann, H. (1995) Gender-specific vocal dysfunctions in Parkinson's disease: electroglottographic and acoustic analyses. Ann. Otol. Rhinol. Laryngol., 104, 197-202.
49. Homann, C.N., Quehenberger, F., Petrovic, K., Hartung, H.P., Ruzicka, E., Homann, B., Suppan, K., Wenzel, K., Ivanic, G. & Ott, E. (2003) Influence of age, gender, education and dexterity on upper limb motor performance in Parkinsonian patients and healthy controls. J. Neural Transm., 110, 885-897.
50. Khosla, T. & Lowe, C.R. (1968) Height and weight of British men. Lancet, 1, 742-745.
51. Kritzer, M.F. (1997) Selective colocalization of immunoreactivity for intracellular gonadal hormone receptors and tyrosine hydroxylase in the ventral tegmental area, substantia nigra, and retrorubral fields in the rat. J. Comp. Neurol., 379, 247-260.
52. Kuhn, A.A., Kupsch, A., Schneider, G.H. & Brown, P. (2006) Reduction in subthalamic 8-35 Hz oscillatory activity correlates with clinical improvement in Parkinson's disease. Eur. J. Neurosci., 23, 1956-1960.
53. Kuhn, A.A., Williams, D., Kupsch, A., Limousin, P., Hariz, M., Schneider, G.H., Yarrow, K. & Brown, P. (2004) Event-related beta desynchronization in human subthalamic nucleus correlates with motor performance. Brain, 127, 735-746.
54. Kuppers, E., Ivanova, T., Karolczak, M. & Beyer, C. (2000) Estrogen: a multifunctional messenger to nigrostriatal dopaminergic neurons. J. Neurocytol., 29, 375-385.
55. Levy, R., Ashby, P., Hutchison, W.D., Lang, A.E., Lozano, A.M. & Dostrovsky, J.O. (2002) Dependence of subthalamic nucleus oscillations on movement and dopamine in Parkinson's disease. Brain, 125, 1196-1209.
56. Limousin, P., Krack, P., Pollak, P., Benazzouz, A., Ardouin, C., Hoffmann, D. & Benabid, A.L. (1998) Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N. Engl. J. Med., 339, 1105-1111.
57. Lindboe, C.F. (2003) Brain weight: what does it mean? Clin. Neuropathol., 22, 263-265.
58. Lyons, K.E., Hubble, J.P., Troster, A.I., Pahwa, R. & Koller, W.C. (1998) Gender differences in Parkinson's disease. Clin. Neuropharmacol., 21, 118-121.
59. Magill, P.J., Sharott, A., Bevan, M.D., Brown, P. & Bolam, J.P. (2004) Synchronous unit activity and local field potentials evoked in the subthalamic nucleus by cortical stimulation. J. Neurophysiol., 92, 700-714.
60. Marceglia, S., Foffani, G., Bianchi, A.M., Baselli, G., Tamma, F., Egidi, M. & Priori, A. (2006) Dopamine-dependent non-linear correlation between subthalamic rhythms in Parkinson's disease. J. Physiol., 571, 579-591.
61. Martinelli, P., Contin, M., Scaglione, C., Riva, R., Albani, F. & Baruzzi, A. (2003) Levodopa pharmacokinetics and dyskinesias: are there sex-related differences? Neurol. Sci., 24, 192-193.
62. Matsumoto, A. & Arai, Y. (1976) Developmental changes in synaptic formation in the hypothalamic arcuate nucleus of female rats. Cell Tissue Res., 169, 143-156.
63. Miller, A.K. & Corsellis, J.A. (1977) Evidence for a secular increase in human brain weight during the past century. Ann. Hum. Biol., 4, 253-257.
64. Miranda, M., Cardoso, F., Giovannoni, G. & Church, A. (2004) Oral contraceptive induced chorea: another condition associated with anti-basal ganglia antibodies. J. Neurol. Neurosurg. Psychiatry, 75, 327-328.
65. Moro, E., Scerrati, M., Romito, L.M., Roselli, R., Tonali, P. & Albanese, A. (1999) Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease. Neurology, 53, 85-90.
66. Murthy, V.N. & Fetz, E.E. (1992) Coherent 25- to 35-Hz oscillations in the sensorimotor cortex of awake behaving monkeys. Proc. Natl. Acad. Sci. USA, 89, 5670-5674.
67. Nikulin, V.V. & Brismar, T. (2006) Phase synchronization between alpha and beta oscillations in the human electroencephalogram. Neuroscience, 137, 647-657.
68. O'Suilleabhain, P.E. & Dewey, R.B. Jr (2002) Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease. Arch. Neurol., 59, 986-989.
69. Priori, A., Ardolino, G., Marceglia, S., Mrakic-Sposta, S., Locatelli, M., Tamma, F., Rossi, L. & Foffani, G. (2006) Low-frequency subthalamic oscillations increase after deep brain stimulation in Parkinson's disease. Brain Res. Bull., 71, 149-154.
70. Priori, A., Egidi, M., Pesenti, A., Rohr, M., Rampini, P., Locatelli, M., Tamma, F., Caputo, E., Chiesa, V. & Barbieri, S. (2003) Do intraoperative microrecordings improve subthalamic nucleus targeting in stereotactic neurosurgery for Parkinson's disease? J. Neurosurg. Sci., 47, 56-60.
71. Priori, A., Foffani, G., Pesenti, A., Tamma, F., Bianchi, A.M., Pellegrini, M., Locatelli, M., Moxon, K.A. & Villani, R.M. (2004) Rhythm-specific pharmacological modulation of subthalamic activity in Parkinson's disease. Exp. Neurol., 189, 369-379.
72. Rampini, P.M., Locatelli, M., Alimehmeti, R., Tamma, F., Caputo, E., Priori, A., Pesenti, A., Rohr, M. & Egidi, M. (2003) Multiple sequential image-fusion and direct MRI localisation of the subthalamic nucleus for deep brain stimulation. J. Neurosurg. Sci., 47, 33-39.
73. Reisert, I., Han, V., Lieth, E., Toran-Allerand, D., Pilgrim, C. &Lauder, J. (1987) Sex steroids promote neurite growth in mesencephalic tyrosine hydroxylase immunoreactive neurons in vitro. Int. J. Dev. Neurosci., 5, 91-98.
74. Sawada, H. & Shimohama, S. (2003) Estrogens and Parkinson disease: novel approach for neuroprotection. Endocrine, 21, 77-79.
75. Segovia, S., Guillamon, A., del Cerro, M.C., Ortega, E., Perez-Laso, C., Rodriguez-Zafra, M. & Beyer, C. (1999) The development of brain sex differences: a multisignaling process. Behav. Brain Res., 105, 69-80.
76. Shearer, D., Cohn, N.B., Dustman, R.E. & Lamarche, J.A. (1984) Electrophysiological correlates of gender differences. Am. JEEG Technol., 24, 95-107.
77. Shulman, L.M. (2002) Is there a connection between estrogen and Parkinson's disease? Parkinsonism Relat. Disord., 8, 289-295.
78. Sibug, R., Kuppers, E., Beyer, C., Maxson, S.C., Pilgrim, C. & Reisert, I. (1996) Genotype-dependent sex differentiation of dopaminergic neurons in primary cultures of embryonic mouse brain. Brain Res. Dev. Brain Res., 93, 136-142.
79. Silberstein, P., Kuhn, A.A., Kupsch, A., Trottenberg, T., Krauss, J.K., Wohrle, J.C., Mazzone, P., Insola, A., Di Lazzaro, V., Oliviero, A., Aziz, T. & Brown, P. (2003) Patterning of globus pallidus local field potentials differs between Parkinson's disease and dystonia. Brain, 126, 2597-2608.
80. Steiger, M.J. & Quinn, N.P. (1991) Hormone replacement therapy induced chorea. BMJ, 302, 762.
81. Thompson, T.L. & Moss, R.L. (1994) Estrogen regulation of dopamine release in the nucleus accumbens: genomic- and nongenomic-mediated effects. J. Neurochem., 62, 1750-1756.
82. Toran-Allerand, C.D. (1976) Sex steroids and the development of the newborn mouse hypothalamus and preoptic area in vitro: implications for sexual differentiation. Brain Res., 106, 407-412.
83. Wada, Y., Takizawa, Y., Jiang, Z.Y. & Yamaguchi, N. (1994) Gender differences in quantitative EEG at rest and during photic stimulation in normal young adults. Clin. Electroencephalogr., 25, 81-85.
84. Williams, D., Kuhn, A., Kupsch, A., Tijssen, M., van Bruggen, G., Speelman, H., Hotton, G., Loukas, C. & Brown, P. (2005) The relationship between oscillatory activity and motor reaction time in the parkinsonian subthalamic nucleus. Eur. J. Neurosci., 21, 249-258.
85. Williams, D., Kuhn, A., Kupsch, A., Tijssen, M., van Bruggen, G., Speelman, H., Hotton, G., Yarrow, K. & Brown, P. (2003) Behavioural cues are associated with modulations of synchronous oscillations in the human subthalamic nucleus. Brain, 126, 1975-1985.
86. Yaar, I. & Shapiro, M.B. (1983) A quantitative study of the electroencephalographic response to levodopa treatment in parkinsonian patients. Clin. Electroencephalogr., 14, 82-85.
87. Zappia, M., Annesi, G., Nicoletti, G., Arabia, G., Annesi, F., Messina, D., Pugliese, P., Spadafora, P., Tarantino, P., Carrideo, S., Civitelli, D., De Marco, E.V., Ciro-Candiano, I.C., Gambardella, A. & Quattrone, A. (2005) Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease: an exploratory study. Arch. Neurol., 62, 601-605.